# SLC4A3

## Overview
The SLC4A3 gene encodes the protein solute carrier family 4 member 3, commonly referred to as anion exchanger 3 (AE3), which is a transmembrane protein involved in the electroneutral exchange of chloride (Cl-) and bicarbonate (HCO3-) ions across the plasma membrane. This protein plays a critical role in maintaining acid-base balance and regulating intracellular pH, particularly in excitable tissues such as the heart, brain, and retina (Romero2004The; Thorsen2017Lossofactivitymutation). AE3 exists in two splice variants, the cardiac form (cAE3) and the brain form (bAE3), each with distinct structural features and tissue distribution (Liu2015Structure). The protein's function is essential for physiological processes such as neuronal excitability and cardiac function, and its dysfunction is associated with various clinical conditions, including cardiac arrhythmias and neurological disorders (Zhong2023Potential; Thorsen2017Lossofactivitymutation).

## Structure
The SLC4A3 gene encodes the AE3 protein, which is an integral membrane protein involved in the electroneutral exchange of Cl- and HCO3- ions across the plasma membrane. The protein is characterized by a long N-terminal hydrophilic domain and a shorter C-terminal hydrophilic domain, both located intracellularly, separated by 10-14 transmembrane segments (Romero2004The). The AE3 protein has two splice variants, known as the cardiac form (cAE3) and the brain form (bAE3), which are expressed in various tissues including the heart, brain, and epithelial cells (Romero2004The; Liu2015Structure).

Structurally, the bAE3 variant has a unique N-terminal region compared to cAE3, with the first 271 amino acids differing from the first 73 amino acids of cAE3 (Liu2015Structure). The AE3 protein is not N-glycosylated, unlike some other members of the SLC4 family, but it may undergo other post-translational modifications such as phosphorylation (Romero2004The). The protein's structure facilitates its role in pH regulation and ion transport, contributing to physiological processes like neuronal excitability and systemic acid-base homeostasis (Liu2015Structure).

## Function
The SLC4A3 gene encodes the anion exchanger AE3, which is crucial for maintaining acid-base balance in cells by facilitating the exchange of chloride (Cl-) and bicarbonate (HCO3-) ions across the cell membrane. This exchange is essential for regulating intracellular pH (pHi) and ensuring normal cardiac function (Thorsen2017Lossofactivitymutation). AE3 is primarily active in excitable tissues such as the heart, brain, and retina, but it is also expressed in epithelial cells, including those of the kidney and gastrointestinal tract (Romero2004The).

In cardiac cells, AE3 plays a significant role in maintaining myocardial pH balance, which is vital for pH recovery from alkaline loads in the heart (Thorsen2017Lossofactivitymutation). The protein's function involves the electroneutral transmembrane exchange of Cl- and HCO3- ions, contributing to the regulation of intracellular and extracellular pH (Liu2015Structure). This activity is critical for various physiological processes, including neuronal excitability modulation and systemic acid-base homeostasis (Liu2015Structure). AE3's proper function is essential for maintaining the duration of cardiac action potentials and the QT interval, which are vital for proper heart rhythm and function (Thorsen2017Lossofactivitymutation).

## Clinical Significance
Mutations in the SLC4A3 gene are associated with several human diseases, particularly cardiac and neurological disorders. In the heart, mutations in SLC4A3 have been linked to Short QT Syndrome (SQTS), an inherited arrhythmogenic disorder. This condition affects potassium and calcium channels, leading to a shortened QT interval, which can result in cardiac arrest, palpitations, and syncope. The mutation impacts intracellular pH and chloride concentration, influencing the activity of other ion channels in myocytes, contributing to arrhythmias (Zhong2023Potential; Thorsen2017Lossofactivitymutation). SLC4A3 mutations are also implicated in catecholaminergic polymorphic ventricular tachycardia (CPVT), another inherited arrhythmia (Zhong2023Potential).

In the nervous system, the Ala867Asp variant in SLC4A3 is associated with idiopathic generalized epilepsy (IGE), leading to decreased transport activity, abnormal intracellular pH, and neuronal hyperexcitability (Zhong2023Potential). Additionally, SLC4A3 mutations have been identified in non-small cell lung cancer (NSCLC) and uterine corpus endometrial carcinoma (UCEC), where they may serve as potential markers and therapeutic targets due to their role in cellular transformation and cancer progression (Zhong2023Potential; White2023What).

## Interactions
The SLC4A3 gene encodes the AE3 protein, a Cl-/HCO3- exchanger involved in various protein interactions crucial for its function in cardiac physiology. AE3 is part of a complex known as the hypertrophic transport metabolon (HTM), which includes interactions with NHE1 and carbonic anhydrase II (CAII). These interactions are essential for promoting cardiomyocyte hypertrophy, as AE3 provides an acid-loading pathway necessary for sustained NHE1 activity, which is implicated in cardiac hypertrophy (Sowah2014Resistance).

AE3 also forms a complex with CAXIV in the myocardium, contributing to hypertrophic growth in certain models (Sowah2014Resistance). The interaction between AE3 and CAII is particularly significant, as CAII modulates hypertrophic growth by interacting with both NHE1 and AE3 to provide their respective transport substrates (Sowah2014Resistance).

In the context of Short QT Syndrome (SQTS), a mutation in AE3 affects its interaction with other proteins, such as Arg370 with Glu376 and Trp385, which are crucial for the protein's function and membrane targeting (Thorsen2017Lossofactivitymutation). These interactions highlight the complex network of protein interactions involving AE3 that contribute to its role in cardiac function and disease.


## References


[1. (Romero2004The) Michael F. Romero, Christiaan M. Fulton, and Walter F. Boron. The slc4 family of hco3 ? transporters. Pfl�gers Archiv European Journal of Physiology, 447(5):495–509, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1180-2, doi:10.1007/s00424-003-1180-2. This article has 362 citations.](https://doi.org/10.1007/s00424-003-1180-2)

[2. (Sowah2014Resistance) Daniel Sowah, Brittany F Brown, Anita Quon, Bernardo V Alvarez, and Joseph R Casey. Resistance to cardiomyocyte hypertrophy in ae3 −/− mice, deficient in the ae3 cl−/hco3 −exchanger. BMC Cardiovascular Disorders, July 2014. URL: http://dx.doi.org/10.1186/1471-2261-14-89, doi:10.1186/1471-2261-14-89. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2261-14-89)

[3. (Liu2015Structure) Ying Liu, Jichun Yang, and Li-Ming Chen. Structure and function of slc4 family hco3- transporters. Frontiers in Physiology, December 2015. URL: http://dx.doi.org/10.3389/fphys.2015.00355, doi:10.3389/fphys.2015.00355. This article has 45 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphys.2015.00355)

[4. (Thorsen2017Lossofactivitymutation) Kasper Thorsen, Vibeke S. Dam, Kasper Kjaer-Sorensen, Lisbeth N. Pedersen, V. Arvydas Skeberdis, Jonas Jurevičius, Rimantas Treinys, Ida M. B. S. Petersen, Morten S. Nielsen, Claus Oxvig, J. Preben Morth, Vladimir V. Matchkov, Christian Aalkjær, Henning Bundgaard, and Henrik K. Jensen. Loss-of-activity-mutation in the cardiac chloride-bicarbonate exchanger ae3 causes short qt syndrome. Nature Communications, November 2017. URL: http://dx.doi.org/10.1038/s41467-017-01630-0, doi:10.1038/s41467-017-01630-0. This article has 86 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-017-01630-0)

[5. (Zhong2023Potential) Jingwen Zhong, Jing Dong, Wenyan Ruan, and Xiaohong Duan. Potential theranostic roles of slc4 molecules in human diseases. International Journal of Molecular Sciences, 24(20):15166, October 2023. URL: http://dx.doi.org/10.3390/ijms242015166, doi:10.3390/ijms242015166. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms242015166)

[6. (White2023What) Bobby White and Pawel Swietach. What can we learn about acid-base transporters in cancer from studying somatic mutations in their genes? Pflügers Archiv - European Journal of Physiology, 476(4):673–688, November 2023. URL: http://dx.doi.org/10.1007/s00424-023-02876-y, doi:10.1007/s00424-023-02876-y. This article has 2 citations.](https://doi.org/10.1007/s00424-023-02876-y)